Salt Composition in both
Salt Composition
Seroquel 100mg(same for both)
You Searched
Strip of 4 tablets
We only sell the best substitute from top brands
Our Recommendation
Seroquel 100mg Tablet 4s
4,960+ Customers trust this
WHO GMP Certified
Marketed by
Doctor ApprovedMedicine Comparison
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
Pantosec DSR 30/40mg PR Capsule 10sPantosec 40mg Tablet 10sCipvildin M 500/50mg Tablet 15sAb Rozu 10mg Tablet 10sCipcal D3 60000IU Capsule 4sCipcal 500mg/250IU Tablet 15sDapaquest 10mg Tablet 10sMontecip LC 5/10mg Tablet 10sLipvas 10mg Tablet 10sParacip 650mg Tablet 10sView More
Aerolife inhalation Device 1sAir Space Wit Exhle Valve Device 1sBp Monitor (Omron) Hem 8712 Device 1sContour Plus System 1sDigital Thermometer Mercury Device 1sDuohaler DPI Device 1sIbreathe DPI Inhealer Device 1sMachaler DPI Device 1sMacspacer Device 1sNovopen 4 | Diabetes Monitoring Devices 1s
entialsDoctor approvedmedicinpatient partnershipsNon-patient partnershipsAll-in-1 Patientogi card patientreliabilitySeroquel 100mg Tablet 4sMedicine ComparisonMedicine ComparisonMedicine ComparisonProduct NameAmrix cureusCureusentin 500mg Tablet 10sCureusentin 400mg Tablet 15sCureusentin 50mg Tablet 10sCureusentin 40mg Tablet 10sAmri-cureus (Cureusentin 500mg)
standaloneavg of ava-covid19-cureus creatinine Sodium creatinine Sodium creatininephosphate creatinine creatinine creatinine creatinine creatinine creatinine creatinine creatinine creatinine creatinine creatinide salt creatinine pigment pigment creatinineconjerence1.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.Brand-name Risperdal Seroquel is at risk for serious and possibly fatal adverse effects.
According to theAmended, patients with severe schizophrenia or bipolar disorder must undergo several months of regular monitoring and treatment with antipsychotic drugs. The following conditions should be monitored, and Risperdal Seroquel patients should be treated with a strong, long-acting antipsychotic drug:
If a patient develops serious symptoms such as hallucinations, delusions, and severe mood swings after taking an atypical antipsychotic drug, Risperdal Seroquel must be discontinued and the patient transferred to the intensive care unit.
Risperdal Seroquel is not approved for patients with severe hepatic impairment. However, it may be prescribed for patients with a history of peptic ulcer disease, metabolic acidosis, or severe hypoglycemia due to drug-metabolizing bacterial infections.
About Risperdal SeroquelRisperdal is marketed by Pfizer and is manufactured by Eli Lilly and is available in 200 mg and 400 mg tablets.
Risperdal Seroquel is not approved for patients with a history of hepatic impairment. However, it may be prescribed for patients with a history of metabolic acidosis and severe hypoglycemia due to drug-heating bacterial infections.
About antipsychotic medicationsRisperdal Seroquel is approved for the treatment of patients with schizophrenia and bipolar disorder. It is also approved for treatment of depression.
About antipsychotic drugsRisperdal Seroquel is approved for the treatment of patients with a history of psychosis, including bipolar disorder. It is also approved for treatment of schizophrenia.
About Risperdal Seroquel (Abilify)Risperdal Seroquel is a brand name for Risperdal. Abilify is a generic drug approved by the FDA to treat schizophrenia. Risperdal Seroquel is available in a generic formulation.
Risperdal (Abilify) is available in generic form. Abilify is a brand name for a generic of Risperdal that is also marketed by Pfizer. These generics are available only with your physician's prescription.
About AbilifyAbilify is an antipsychotic medication that is used to treat the following conditions:
Abilify should not be used in combination with any other medications for treating bipolar disorder.
Abilify is a brand name for quetiapine hydrochloride, USP. Abilify is also available as a generic formulation.
The drug's manufacturer, AstraZeneca, said it has received US Food and Drug Administration approval for Seroquel 200 mg tablets, which are being manufactured in the US. (AP Photo/Richard Drew, File)
Seroquel 200 mg is the brand name for the Seroquel-based drug that is being used to treat schizophrenia and bipolar disorder.
The drug's maker, AstraZeneca, has received a similar FDA approval for Seroquel 5.5 mg, which is used to treat major depressive disorder and other psychiatric disorders.
Seroquel 200 mg tablets are also being manufactured in Canada, the US, and Australia, which are also on the market.
The drug’s manufacturer, AstraZeneca, has received a similar FDA approval for Seroquel 5.5 mg, which is used to treat major depressive disorder and other psychiatric disorders.
The drug’s maker, AstraZeneca, has received a similar FDA approval for Seroquel 5.5 mg, which is used to treat schizophrenia and bipolar disorder.
Seroquel 200 mg tablets are the brand name for the drug Seroquel-based, which is used to treat schizophrenia and bipolar disorder.
The drug’s manufacturer, AstraZeneca, has received a similar FDA approval for Seroquel 5.5 mg, which is used to treat schizophrenia and bipolar disorder.
Sold and Supplied by Healthylife Pharmacy
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
Medicare CardNo MedicareConcession
$40.95
This product is temporarily unavailable.
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
iaries30% off on prescription treatsStrictLY legal
Healthylife.au.gov.au.nor does Healthylife suggest that you provide any medical advice or information within the last 30 days or in the past. Please leave only what you have read on the packaging.The packaging is sealed
Strictly regulated
Antipsychotic drugs may help treat schizophrenia. There are several antipsychotic drugs, but most are associated with extrapyramidal symptoms (EPS). In general, the risk of EPS is low when first prescribed antipsychotic medications.
Atypical antipsychotics have been associated with an increased risk of EPS in patients who use them, but the incidence is not high. The risk for EPS in the first year after starting antipsychotic medication may be higher in the first 3 months of treatment. The risk of EPS in patients with bipolar I disorder or atypical antipsychotic treatment is about 1% and 1% for adults and children, respectively.
Atypical antipsychotics are generally not as effective as the usual antipsychotics for the treatment of bipolar I disorder, but they may still be associated with a lower risk of EPS. In a large study, the risk of EPS was significantly higher in patients who used an atypical antipsychotic who were also on a standard of care treatment, and this risk decreased in subsequent weeks of treatment. The risk of EPS in patients who use atypical antipsychotics who also have a diagnosis of bipolar disorder is about 1% in patients who also have a diagnosis of schizophrenia, and this risk can be increased in patients who have received another antipsychotic, but have not received the standard of care treatment for bipolar I disorder.
Atypical antipsychotics are a class of drugs that may be helpful in treating bipolar I disorder and have been used to treat schizophrenia. They include:
Atypical antipsychotic medications can have a very small risk of EPS. This is probably because the risk for EPS in patients with schizophrenia is lower compared to those who do not have a diagnosis of schizophrenia. In addition, there is no evidence that the risk of EPS is different for patients taking atypical antipsychotics, and the risk is higher for patients taking other medications or other atypical antipsychotics. There is no strong evidence that atypical antipsychotics are superior to the usual antipsychotics for the treatment of bipolar I disorder.
The risk of EPS in patients taking atypical antipsychotic medications is about 1% in the first year after starting medication. The risk of EPS in patients with a diagnosis of schizophrenia increases by approximately 2% in the first year after starting medication.
Atypical antipsychotic medications may interact with another antipsychotic drug, such as risperidone, lithium, or a selective serotonin reuptake inhibitor (SSRI). This may increase the risk of EPS.
In addition, there are some studies that have shown that EPS can be reduced with some of the medications that are associated with EPS. These include:
Atypical antipsychotics may have a similar risk of EPS.
The risk for EPS in patients taking atypical antipsychotic medications is about 1% in the first year after starting medication.
The risk of EPS is different for patients taking atypical antipsychotic medications, as there is no strong evidence that it is different for patients taking other medications.
The risk of EPS in patients with CNS side effects may be higher in the first year after starting medication.
Stade de France Pharmacy